# Progress Note 06 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Robert Peary (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX004-SYN-TD
- Date: 1919-03-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Thaddeus Lindgren-Okafor, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Admiral Peary is a 62-year-old retired naval officer with pernicious anemia, now with normal blood counts on weekly cyanocobalamin injections, recovering subacute combined degeneration, autoimmune atrophic gastritis, iron deficiency on oral iron, and old frostbite amputations of the toes, who comes for his preventive visit two weeks after his eight-week review. His energy is much better and he walks a mile with his stick. The numbness in his feet has eased but not gone. The blister on his left forefoot has healed. He takes the iron every other day without stomach upset. He has never had shingles or pneumococcal vaccines, and his last tetanus booster was six years ago. He received influenza and COVID-19 vaccines in the autumn. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 62 |
| Pernicious anemia | Weekly injections; blood count normal two weeks ago |
| Feet | Numbness easing; blister healed |
| Mood | PHQ-2 0 |
| Medicines | Cyanocobalamin 1,000 micrograms into the muscle weekly; ferrous sulfate 325 mg every other day |

## Health risk assessment

Completed by the patient on paper in the waiting room and reviewed with him by Dr. Lindgren-Okafor. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and much better than in the winter |
| Psychosocial | Lives with his wife; writes and lectures; the old dispute over his claim still troubles him at times |
| Alcohol | A glass of wine with dinner a few times a week; AUDIT-C 2 at intake |
| Tobacco | Never |
| Physical activity | Walks a mile most days with a stick; balance exercises from physical therapy |
| Nutrition | Mixed diet with meat, fish and dairy; takes the iron with orange juice, apart from tea |
| Sleep | Seven hours |
| Safety at home | Night lights fitted; loose rugs removed; no firearms at home |
| Falls | No falls since intake; still careful on ice |
| Activities of daily living | Independent |
| Hearing and vision | Mild trouble hearing in crowds; reading glasses |
| Oral health | Dentures for some back teeth; dental visit last year |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy much better; weight up 1.8 kg since intake |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Positive | Mild trouble hearing in crowds; tongue no longer sore |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | No breathlessness on stairs |
| Gastrointestinal | Negative | No indigestion, black stools or abdominal pain on iron |
| Genitourinary | Negative | No urinary hesitancy or nocturia beyond once a night |
| Musculoskeletal | Negative | No joint pain or swelling |
| Integumentary | Negative | Feet checked daily; blister healed; no new wounds |
| Neurological | Positive | Numbness at the ends of both feet, less than before; balance better |
| Psychiatric | Negative | Mood good; PHQ-2 0 |

11 systems reviewed. **S**

## Current medications

- Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a week while the nerves recover **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet every other day on an empty stomach with a glass of orange juice **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/74 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 74.2 kg; BMI 22.2 kg/m². All vital signs are synthetic.

PHQ-2: 0; Total cholesterol: 196 mg/dL; HDL cholesterol: 58 mg/dL; LDL cholesterol (calculated): 118 mg/dL (high); Triglycerides: 100 mg/dL. All results are synthetic.

## Immunizations given today

- Recombinant zoster vaccine, first of two doses **S**
- Pneumococcal conjugate vaccine (PCV20), single dose **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 74.2 kg, BMI 22.2; blood pressure 126/74; pulse 72 and regular |
| Ears, nose, mouth, and throat | Ear canals clear; whispered voice heard at arm's length; tongue normal |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur; foot pulses present |
| Respiratory | Clear to auscultation |
| Abdomen | Soft and non-tender |
| Skin | Healed blister site on the left forefoot; old amputation stumps intact |
| Neurological | Vibration reduced at the ankles; Romberg test swaying but not falling; gait steadier |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. Lipid panel: total cholesterol 196, HDL 58, LDL 118 and triglycerides 100 mg/dL; with blood pressure 126/74, no smoking and no diabetes, his estimated 10-year cardiovascular risk is under 10 percent with no other risk factor, so a statin is not indicated now. **S**
   - Zoster vaccine (first dose) and PCV20 today; second zoster dose in two to six months.
   - HIV, hepatitis C and hepatitis B screening drawn today.
   - Next preventive visit in one year.
2. **Pernicious anemia** (D51.0). Normal blood count on weekly injections; neurological recovery continuing. **S**
   - Continue weekly injections until the fifteen-week review.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 126/74 mmHg |
| Lipid screening and cardiovascular risk | Completed today | Total cholesterol 196, HDL 58, LDL 118, triglycerides 100 mg/dL; 10-year risk under 10 percent; statin not indicated |
| Diabetes screening | Up to date | HbA1c 5.5% at intake |
| Colorectal cancer screening | Up to date | Colonoscopy five weeks ago without polyps; repeat in ten years |
| Lung cancer screening | Not indicated | Never smoked |
| Abdominal aortic aneurysm screening | Not indicated | For men 65 to 75 who have ever smoked |
| Prostate cancer screening | Declined | Shared decision-making at 55 to 69; after discussing benefits and harms he chose not to have a PSA test |
| HIV screening | Ordered | Once for adults to 65; drawn today |
| Hepatitis C screening | Ordered | Once for all adults; drawn today |
| Hepatitis B screening | Ordered | Triple panel once for all adults; drawn today |
| Depression screening | Completed today | PHQ-2 0 |
| Unhealthy alcohol use | Up to date | AUDIT-C 2 at intake |
| Falls risk | Up to date | Assessed at each visit because of the neuropathy; physical therapy for balance under way |
| Zoster vaccine | Completed today | First recombinant dose today; second in two to six months |
| Pneumococcal vaccine | Completed today | PCV20 today, recommended from 50; no further dose needed |
| Tetanus, diphtheria, and pertussis | Up to date | Booster six years ago |
| Influenza and COVID-19 vaccines | Up to date | Given last autumn |
| RSV vaccine | Not indicated | Recommended at 50 to 74 only with conditions that raise risk; none |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying independent, walking, and being able to write. He chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. **S**

## Guideline basis

- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022), U.S. Preventive Services Task Force
- Prostate Cancer: Screening (2018), U.S. Preventive Services Task Force
- Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 (2023), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Fifteen-week review in five weeks. HIV, hepatitis C and hepatitis B results by phone. Second zoster dose in two to six months. Next preventive visit in one year. **S**
- Next scheduled visit 1919-04-28: fifteen-week review: neurological recovery, iron, lifelong maintenance and the plan ahead. **S**
